"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Excess insulin administration may cause hypoglycemia and hypokalemia [see WARNINGS AND PRECAUTIONS] Mild episodes of hypoglycemia can be treated with oral glucose. Adjustments in drug dosage, meal patterns, or physical activity level may be needed. More severe episodes with coma, seizure, or neurologic impairment may be treated with intramuscular/subcutaneous glucagon or concentrated intravenous glucose. Sustained carbohydrate intake and observation may be necessary because hypoglycemia may recur after apparent clinical recovery. Hypokalemia must be corrected appropriately.
HUMULIN 70/30 is contraindicated:
- During episodes of hypoglycemia [see WARNINGS AND PRECAUTIONS], and
- In patients who have had hypersensitivity reactions to HUMULIN 70/30 or any of its excipients [see WARNINGS AND PRECAUTIONS].
Last reviewed on RxList: 1/27/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Humulin 70-30 Information
Humulin 70-30 - User Reviews
Humulin 70-30 User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.